| Doxorubicin | Approved Investigational | UGCG | 7357 |
downregulated | Doxorubicin results in decreased expression of UGCG mRNA | 9q31.3 | |
| Doxorubicin | Approved Investigational | UGCG | 7357 |
upregulated | Doxorubicin results in increased expression of UGCG mRNA | 9q31.3 | |
| Doxorubicin | Approved Investigational | UGT2B4 | 7363 |
downregulated | Doxorubicin results in decreased expression of UGT2B4 mRNA | 4q13.3 | |
| Doxorubicin | Approved Investigational | UPP1 | 7378 |
downregulated | Doxorubicin results in decreased expression of UPP1 mRNA | 7p12.3 | |
| Doxorubicin | Approved Investigational | UQCRH | 7388 |
downregulated | Doxorubicin results in decreased expression of UQCRH mRNA | 1p33 | |
| Doxorubicin | Approved Investigational | VDR | 7421 |
upregulated | Doxorubicin results in increased expression of VDR mRNA | 12q13.11 | |
| Doxorubicin | Approved Investigational | VEGFA | 7422 |
downregulated | Doxorubicin results in decreased expression of VEGFA mRNA | 6p21.1 | |
| Doxorubicin | Approved Investigational | VEGFA | 7422 |
upregulated | Doxorubicin results in increased expression of VEGFA mRNA | 6p21.1 | |
| Doxorubicin | Approved Investigational | VOPP1 | 81552 |
downregulated | Doxorubicin results in decreased expression of VOPP1 mRNA | 7p11.2 | |
| Doxorubicin | Approved Investigational | WNT3 | 7473 |
downregulated | Doxorubicin results in decreased expression of WNT3 mRNA | 17q21.31-q21.32 | |
| Doxorubicin | Approved Investigational | WNT4 | 54361 |
upregulated | Doxorubicin results in increased expression of WNT4 mRNA | 1p36.12 | |
| Doxorubicin | Approved Investigational | XBP1 | 7494 |
upregulated | Doxorubicin results in increased expression of XBP1 mRNA | 22q12.1 | |
| Doxorubicin | Approved Investigational | XIAP | 331 |
downregulated | Doxorubicin results in decreased expression of XIAP mRNA | Xq25 | |
| Doxorubicin | Approved Investigational | XIAP | 331 |
upregulated | Doxorubicin results in increased expression of XIAP mRNA | Xq25 | |
| Doxorubicin | Approved Investigational | ZMAT3 | 64393 |
upregulated | Doxorubicin results in increased expression of ZMAT3 mRNA | 3q26.32 | |
| Doxorubicin | Approved Investigational | ZMYM2 | 7750 |
upregulated | Doxorubicin results in increased expression of ZMYM2 mRNA | 13q12.11 | |
| Doxorubicin | Approved Investigational | ZNF22 | 7570 |
downregulated | Doxorubicin results in decreased expression of ZNF22 mRNA | 10q11.21 | |
| Doxycycline | Approved Investigational Vet Approved | CYP1B1 | 1545 |
upregulated | [Doxycycline results in increased expression of AHR protein] which results in increased expression of CYP1B1 mRNA | 2p22.2 | |
| Doxycycline | Approved Investigational Vet Approved | MMP13 | 4322 |
upregulated | Doxycycline results in increased expression of MMP13 mRNA | 11q22.2 | |
| Doxycycline | Approved Investigational Vet Approved | UGT1A10 | 54575 |
upregulated | Doxycycline results in increased expression of UGT1A10 mRNA | 2q37.1 | |
| Doxycycline | Approved Investigational Vet Approved | UGT1A8 | 54576 |
upregulated | Doxycycline results in increased expression of UGT1A8 mRNA | 2q37.1 | |
| Dronedarone | Approved Investigational | SOD2 | 6648 |
upregulated | dronedarone results in increased expression of SOD2 mRNA | 6q25.3 | |
| Dutasteride | Approved Investigational | ADI1 | 55256 |
downregulated | Dutasteride results in decreased expression of ADI1 mRNA | 2p25.3 | |
| Dutasteride | Approved Investigational | AKR1C1 | 1645 |
upregulated | Dutasteride results in increased expression of AKR1C1 mRNA | 10p15.1 | |
| Dutasteride | Approved Investigational | AKR1C2 | 1646 |
upregulated | Dutasteride results in increased expression of AKR1C2 mRNA | 10p15.1 | |